Income investors hunting for double-digit yields keep landing on the YieldMax Ultra Option Income Strategy ETF (NYSEARCA:ULTY), a weekly-paying fund that has built a $2.48 billion asset base in roughly two years. The pitch is simple: collect cash every Friday from a portfolio of high-volatility names. The reality is more complicated, and the distribution data ... ULTY’s Weekly Payouts Collapsed 80...
Income investors hunting for double-digit yields keep landing on the YieldMax Ultra Option Income Strategy ETF (NYSEARCA:ULTY), a weekly-paying fund that has built a $2.48 billion asset base in roughly two years. The pitch is simple: collect cash every Friday from a portfolio of high-volatility names. The reality is more complicated, and the distribution data ... ULTY’s Weekly Payouts Collapsed 80% in 2025, Now Recovering to $0.40
Piotr Swat | SOPA Images | Lightrocket | Getty Images Major health insurers appear to be off to an encouraging start this year — but a crucial test for the sector is still ahead. Solid first-quarter results have helped lift investor sentiment, even as insurers continue to grapple with higher medical costs. Companies including UnitedHealth , Elevance , Cigna and Humana all beat estimates for the qu...
Piotr Swat | SOPA Images | Lightrocket | Getty Images Major health insurers appear to be off to an encouraging start this year — but a crucial test for the sector is still ahead. Solid first-quarter results have helped lift investor sentiment, even as insurers continue to grapple with higher medical costs. Companies including UnitedHealth , Elevance , Cigna and Humana all beat estimates for the quarter, with some hiking their 2026 outlooks. Those results were largely expected due to seasonal factors such as a milder flu season and weather disruptions that temporarily suppressed medical costs, said Barclays analyst Andrew Mok. A more meaningful signal, Mok said, is that insurers strengthened medical reserves — money set aside to pay future claims — adding a cushion that could support their outlooks. But there's still a "huge caveat," according to Baird analyst Michael Ha. Insurers have incomplete data on medical costs in the first quarter due to a lag in claims processing, as expenses like hospital stays and procedures can take one or two months to be fully reviewed and reimbursed. By the end of the quarter, companies may only have "real hard claims data" from January, so "we always tell investors to take the first quarter with a grain of salt," Ha said. That sets up the second quarter as the real proving ground. As those delayed claims come in, insurers and investors can get a clearer read on whether medical costs are actually tracking as expected, whether companies have priced their plans appropriately and how their earnings could be shaping up for the rest of the year. "The second quarter is the real underwriting hurdle to pay attention to as you get more claims data that crystallizes your performance for the year in a bigger way," Ha said. "If you clear that hurdle, that could imply positive earnings implications for 2026." A solid first quarter Beneath the surface, insurers' stronger start to the year also reflects steps they've taken to rein in costs after two ...
CEO Jacob Walthour, Kourtney Gibson and The 49th Vice President of the United States, Kamala Harris onstage at the 2026 Power100 Honoree Dinner at Beverly Wilshire, A Four Seasons Hotel on May 3, 2026 in Beverly Hills, California. Arnold Turner | Getty Images The Power100 gathering on the sidelines of the Milken Institute Global Conference took on a different tone this year as its diverse leaders ...
CEO Jacob Walthour, Kourtney Gibson and The 49th Vice President of the United States, Kamala Harris onstage at the 2026 Power100 Honoree Dinner at Beverly Wilshire, A Four Seasons Hotel on May 3, 2026 in Beverly Hills, California. Arnold Turner | Getty Images The Power100 gathering on the sidelines of the Milken Institute Global Conference took on a different tone this year as its diverse leaders in finance attendees fight to reclaim the narrative about people of color and women . "We are trying to show the world what success looks like," said Jacob Walthour , co-founder of Power100 and founder and CEO of Blueprint Capital. "And over the course of the last year, what success looks like has been redefined in a way that has not been respectful and not truthful about the contributions of women and people of color." President Donald Trump , who campaigned on and speaks often about rolling back diversity, equity and inclusion measures in both the federal government and the private sector, was not mentioned at the conference, but the impact of his policies were clearly on the minds of attendees. In his first week back in office in 2025, Trump issued a series of executive orders targeting DEI initiatives at federal agencies and private-sector businesses. The Power100 meeting — in its third year — is hosted by Blueprint Capital Advisors in Beverly Hills, Calif., convening diverse leaders in alternative capital management , a field predominantly led by white men. According to a 2025 Government Accountability Office report , minority- and women-owned firms only manage 1.4% of the approximately $82 trillion in assets under management in the U.S. Shundrawn Thomas , founder of the Copia Group investment firm attended for the first time this year, with the goal of building networks and opportunities to combat trends he sees as concerning. "We've been through a period where there has been an implication that capital and opportunity was flowing to women and people of color that wer...
RESEARCH TRIANGLE PARK, N.C., May 05, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted six newly-hired employees restricted stock units (RSUs) covering an aggregate of 61,750 shares of BioCryst common stock. The RSUs were granted as of May 1, 2026, as inducements material to each employee...
RESEARCH TRIANGLE PARK, N.C., May 05, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted six newly-hired employees restricted stock units (RSUs) covering an aggregate of 61,750 shares of BioCryst common stock. The RSUs were granted as of May 1, 2026, as inducements material to each employee entering into employment with BioCryst. The RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4).
WALTHAM, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its first quarter of 2026, covering the three-month period ended March 31, 2026. The Company is also providing updated financial guidance for the full year 2026.
WALTHAM, Mass., May 05, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today reported financial results for its first quarter of 2026, covering the three-month period ended March 31, 2026. The Company is also providing updated financial guidance for the full year 2026.
ST. LOUIS, May 05, 2026 (GLOBE NEWSWIRE) -- BellRing Brands, Inc. (NYSE:BRBR) (“BellRing”), a holding company operating in the global proactive wellness category, today reported results for the second fiscal quarter ended March 31, 2026.
ST. LOUIS, May 05, 2026 (GLOBE NEWSWIRE) -- BellRing Brands, Inc. (NYSE:BRBR) (“BellRing”), a holding company operating in the global proactive wellness category, today reported results for the second fiscal quarter ended March 31, 2026.
Same-restaurant sales growth of 2.8% Total revenues increased 17.3% Net loss of $(2.7) million and Adjusted EBITDA of $27.8 million 16 new system-wide restaurants opened in 11 states
Same-restaurant sales growth of 2.8% Total revenues increased 17.3% Net loss of $(2.7) million and Adjusted EBITDA of $27.8 million 16 new system-wide restaurants opened in 11 states
MALTA, N.Y., May 05, 2026 (GLOBE NEWSWIRE) -- GLOBALFOUNDRIES Inc. (GF) (Nasdaq: GFS) today announced preliminary financial results for the first quarter ended March 31, 2026.
MALTA, N.Y., May 05, 2026 (GLOBE NEWSWIRE) -- GLOBALFOUNDRIES Inc. (GF) (Nasdaq: GFS) today announced preliminary financial results for the first quarter ended March 31, 2026.
-- IMCIVREE ® (setmelanotide) launched in the U.S. for acquired hypothalamic obesity; more than 150 patient start forms received in the first six weeks following FDA approval on March 19, 2026 -- -- First quarter 2026 net product revenue from global sales of IMCIVREE of $60.1 million -- -- IMCIVREE granted Marketing Authorization by European Commission for the treatment of obesity and control of h...
-- IMCIVREE ® (setmelanotide) launched in the U.S. for acquired hypothalamic obesity; more than 150 patient start forms received in the first six weeks following FDA approval on March 19, 2026 -- -- First quarter 2026 net product revenue from global sales of IMCIVREE of $60.1 million -- -- IMCIVREE granted Marketing Authorization by European Commission for the treatment of obesity and control of hunger in patients with acquired hypothalamic obesity --
Senator Ted Cruz (R-Tx.) sits down with Yahoo Finance Executive Editor Brian Sozzi at the. Milken Institute's Global Conference 2026 to further discuss his state's involvement in the AI boom, while also addressing some of the regulations on artificial intelligence that he is pushing for.
Senator Ted Cruz (R-Tx.) sits down with Yahoo Finance Executive Editor Brian Sozzi at the. Milken Institute's Global Conference 2026 to further discuss his state's involvement in the AI boom, while also addressing some of the regulations on artificial intelligence that he is pushing for.
PeterPhoto/iStock Unreleased via Getty Images Despite a big bid from GameStop Corp. ( GME ), eBay, Inc. ( EBAY ) didn't soar on the announcement over the weekend. The market wasn't overly impressed by the proposal for the combination with a struggling retailer. My investment thesis remains bullish on the stock, though the merger proposal isn't overly enticing. Finviz GameStop Proposal GameStop sub...
PeterPhoto/iStock Unreleased via Getty Images Despite a big bid from GameStop Corp. ( GME ), eBay, Inc. ( EBAY ) didn't soar on the announcement over the weekend. The market wasn't overly impressed by the proposal for the combination with a struggling retailer. My investment thesis remains bullish on the stock, though the merger proposal isn't overly enticing. Finviz GameStop Proposal GameStop submitted a non-binding proposal to acquire eBay for $125 per share. The stock entered the week trading at $100 due in part to GameStop accumulating a large position and the market rumors of a potential bid. The proposal values eBay at $55.5 billion, with the offer comprising 50% cash and 50% GameStop common stock. Naturally, the acquirer wants to go back and claim the offer is a sizable 36% premium to the 90-day VWAP and 46% above the unaffected close, but one has to really question how much a 5% position obtained at least partially through derivatives pushed eBay higher. The immediate problem is the size of the companies involved in the merger. GameStop has a market cap of ~$11 billion, while eBay is valued at $56 billion via this offer. The gaming company has to take on substantial debt to complete the deal and massively dilute existing shareholders. While eBay shareholders only cash out 50% of their investment, with the remaining amount in stock. GameStop CEO Ryan Cohen went on CNBC to discuss the merger, and he likely provided eBay shareholders with no confidence in how the merger closes. The company claims a letter from TD Securities for up to $20 billion in financing, but eBay needs far more than a letter. The company has a cash balance of ~$9.4 billion, but GameStop also has $4.2 billion in debt. The retailer can finally put that cash to work, but the debt load ends up at a sizable $23 billion. Outside of the financing questions, Ryan Cohen didn't go to great lengths to explain the rationale for the merger. The primary focus appears to be $2 billion in annualized cost ...
Facebook and Instagram have a new way to detect and remove users under 13: AI bone structure analysis. In a blog post on Tuesday , Meta - Facebook and Instagram's parent company - says its AI system will scan photos and videos posted to its platforms for "general themes and visual cues," including height and bone structure. "We want to be clear: this is not facial recognition," Meta says in the bl...
Facebook and Instagram have a new way to detect and remove users under 13: AI bone structure analysis. In a blog post on Tuesday , Meta - Facebook and Instagram's parent company - says its AI system will scan photos and videos posted to its platforms for "general themes and visual cues," including height and bone structure. "We want to be clear: this is not facial recognition," Meta says in the blog post, adding that it "does not identify the specific person in the image." This system is part of Meta's efforts to keep kids under 13 off its platforms, and will also analyze posts, comments, bios, and captions to search for "contextual clues" t … Read the full story at The Verge.
Meta Platforms is expanding AI-powered age verification and teen protections across Instagram and Facebook, but the impact on growth is likely to differ sharply from Roblox’s recent slowdown.
Meta Platforms is expanding AI-powered age verification and teen protections across Instagram and Facebook, but the impact on growth is likely to differ sharply from Roblox’s recent slowdown.
Seeking Alpha More on Pfizer Pfizer: Why You Should Double Down Into Q1 Pfizer Could Surprise Again This Earnings Season (Preview) Pfizer: Painful Recovery Underway Pfizer beats Q1 street views Pfizer Q1 preview: Analysts bullish on robust pipeline; comments on obesity pipeline, guidance in focus
Seeking Alpha More on Pfizer Pfizer: Why You Should Double Down Into Q1 Pfizer Could Surprise Again This Earnings Season (Preview) Pfizer: Painful Recovery Underway Pfizer beats Q1 street views Pfizer Q1 preview: Analysts bullish on robust pipeline; comments on obesity pipeline, guidance in focus